Joseph P. Erinjeri, MD, PhD
Interventional Radiologist & Early Drug Development Specialist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
My Specialties
- Thermal Ablation of Tumors
- Tumor Embolization
- Mediport Placement
About Me
- Director IR at Koch
I am an interventional oncologist, a type of interventional radiologist who uses image-guided, minimally invasive techniques to perform procedures to treat cancer.
Rather than making a surgical incision, I perform procedures using miniaturized instruments, many of which are small enough to be used through a needle or catheter. Because of these innovations, many of the procedures I perform use only sedation, without the need of a breathing tube or an overnight stay.
Read more
The first experience most patients have with an interventional radiologist is during either a biopsy (to diagnose cancer) or a mediport placement (to begin chemotherapy). Unlike open surgical biopsies, which require a surgical incision, the biopsies I perform are done using a tiny acupuncture-like needle. Nearly all patients go home the same day, and a diagnosis is usually made within two to three days after the biopsy. During mediport placement, I work with each individual’s body and needs to place a mediport that allows effective delivery of chemotherapy through a small, cosmetically pleasing device.
I am recognized nationally and internationally for my expertise in image-guided thermal ablation of tumors, a technique that involves heating or cooling tumors to temperatures that kill tumor cells while preserving the surrounding normal tissue. I lecture extensively on thermal ablation, and have published papers on the subject. In addition, I am the principal investigator on a study investigating the mechanisms by which thermal ablation kills tumor cells. I have a particular interest in the treatment of soft tissue sarcoma, and am a member of the Memorial Sloan Kettering Soft Tissue Sarcoma Disease Management Team. As a member of this team, I collaborate with the best minds at Memorial Sloan Kettering to ensure I am providing the optimal therapy for sarcoma patients.
My goal as an interventional oncologist is to provide the best patient-care experience possible. Because interventional radiology procedures are performed using image guidance, an important component of each clinic visit is to review the new scans that guide your care. I demand excellence of myself and my staff, and I focus on providing care that is appropriate, thoughtful, and best serves the needs of my patient.
An interventional (IN-ter-VEN-shun-al) radiologist is a doctor with special training in using image-guided procedures to diagnose and treat disease.
An early drug development specialist tests new drugs to treat cancer. They have special training in research studies, known as clinical trials.
My Specialties
- Thermal Ablation of Tumors
- Tumor Embolization
- Mediport Placement
- Image Guided Biopsy
- Central Venous Access Placement
Education
- MD, PhD, Washington University School of Medicine (St. Louis)
Residencies
- Mallinckrodt Institute of Radiology, Washington University School of Medicine
Fellowships
- Weill Cornell Medical College
- Memorial Sloan Kettering Cancer Center
Board Certifications
- Interventional Radiology
- Diagnostic Radiology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
PPO
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
PPO, HMO, DSN
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
Contact and Location
Dr. Erinjeri sees patients at one location.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Co-Investigated by Dr. Erinjeri
- A Phase III Study of Durvalumab, Tremelimumab, and Transarterial Chemoembolization (TACE) Given with or without Lenvatinib Compared to TACE Alone in People with Localized Liver Cancer
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Erinjeri’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Joseph P. Erinjeri discloses the following relationships and financial interests:
-
AstraZeneca
Professional Services and Activities
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].